TickerFactsScreenerDevelopers

Xilio Therapeutics, Inc. (XLO) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2020: -$36.09M2021: -$80.75M2022: -$75.72M2023: -$68.62M2024: -$18.38M2025: -$4.99M-$4.99M
2020Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$4.99M+72.8%
2024-$18.38M+73.2%
2023-$68.62M+9.4%
2022-$75.72M+6.2%
2021-$80.75M-123.7%
2020-$36.09M—